Send your virology questions and comments (email or mp3 file) to twiv@microbe.tv or leave voicemail at Skype: twivpodcast. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twiv.
2 thoughts on “TWiV 80: How much X could a woodchuck chuck?”
shahidjameel
Nice discussion on HBV. Great to hear all about the enigmatic X gene of HBV. I worked on it as a postdoc in the mid-80s and published the first expression of recombinant X protein. A colleague in my current group has developed a transgenic mouse model in which X collaborates with c-myc to cause massive liver tumors, in a background in which either gene alone does not. Its a nice model to study molecular details of the progression of HBV-mediated tumors.
A comment on Mike's comment on the high cost of HBV vaccines. It has more to do with greed than anything else. Twenty years back we bought the Engerix vaccine in India at Rupees 500 (~$11) per dose. Three Indian pharma companies produced recombinant vaccines in the late 90s, and now the vaccine can be purchased at Rs. 60 (~$1.3) per dose; even Engerix sells in India now at a far lower price. The price for Government bulk purchase programs in India is only about 50 cents per dose. Only at these rates will it be possible introduce universal immunization and to start dreaming about eradicating hepatitis B.
Nice discussion on HBV. Great to hear all about the enigmatic X gene of HBV. I worked on it as a postdoc in the mid-80s and published the first expression of recombinant X protein. A colleague in my current group has developed a transgenic mouse model in which X collaborates with c-myc to cause massive liver tumors, in a background in which either gene alone does not. Its a nice model to study molecular details of the progression of HBV-mediated tumors.
A comment on Mike's comment on the high cost of HBV vaccines. It has more to do with greed than anything else. Twenty years back we bought the Engerix vaccine in India at Rupees 500 (~$11) per dose. Three Indian pharma companies produced recombinant vaccines in the late 90s, and now the vaccine can be purchased at Rs. 60 (~$1.3) per dose; even Engerix sells in India now at a far lower price. The price for Government bulk purchase programs in India is only about 50 cents per dose. Only at these rates will it be possible introduce universal immunization and to start dreaming about eradicating hepatitis B.
Loved this podcast.